We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clinical Trial Results: Immune Therapy Reduces Risk of Aggressive Breast Cancer Recurrence

News   Feb 26, 2020 | By Molly Campbell, Science Writer, Technology Networks

 
Clinical Trial Results: Immune Therapy Reduces Risk of Aggressive Breast Cancer Recurrence

Credit: Sarah Cervantes on Unsplash.

 
 
Advertisement
 

RELATED ARTICLES

World-first "Fast-fail" Trial Examines Loss of Pleasure in Mood Disorders

News

A first-of-its-kind trial has demonstrated that a receptor involved in the brain’s reward system may be a viable target for treating anhedonia (or lack of pleasure), a key symptom of several mood and anxiety disorders. This innovative fast-fail trial was funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, and the results of the trial are published in Nature Medicine.

READ MORE

Biological "Atlas" Reveals Immune Cell's Dual Personality

News

Scientists have mapped the epigenetic controls on T cells, which could aid Type 1 diabetes diagnosis and treatment, as well as cancer immunotherapy.

READ MORE

Using Stem Cells To Combat COVID-19 Pneumonia

News

Researchers report that intravenous transplantation of human mesenchymal stem cells appears to be safe and effective for treatment in seven patients with COVID-19 pneumonia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE